Clinical trials
Gastroesophageal Reflux trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 8 |
| Terminated | 3 |
| Unknown status | 3 |
| Withdrawn | 2 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prof Urs Zingg | 3 |
| University of Zurich | 3 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 3 |
| AstraZeneca | 2 |
| Edwards Lifesciences | 2 |
| Implantica CE Reflux Ltd. | 2 |
| Takeda | 2 |
| Addex Pharma S.A. | 1 |
| Brain-Gut Research Group | 1 |
| Cleveland Clinic London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastroesophageal Reflux | 31 |
| Diabetes Mellitus, Type 2 | 2 |
| Lymphoma, Follicular | 2 |
| Mitral Valve Insufficiency | 2 |
| Obesity | 2 |
| Stomach Ulcer | 2 |
| Asthma | 1 |
| Body Weight | 1 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus | 1 |
Trials
Showing 76 to 31 of 31. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.